Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses

References

• Dymova MA, Taskaev SY, Richter VA, Kuligina EV. Boron neutron capture therapy: current status and future perspectives. Cancer Commun. 2020;40(9):406–421. doi:10.1002/cac2.12089
   Web of Science ®Google Scholar
• Hu K, Yang Z, Zhang L, et al. Boron agents for neutron capture therapy. Coord Chem Rev. 2020;405:213139. doi:10.1016/j.ccr.2019.213139
   Web of Science ®Google Scholar
• Suzuki M, Sakurai Y, Hagiwara S, et al. First attempt of boron neutron capture therapy (BNCT) for hepatocellular carcinoma. Jpn J Clin Oncol. 2007;37(5):376–381. doi:10.1093/jjco/hym039
   PubMed Web of Science ®Google Scholar
• Chou FI, Chung HP, Liu HM, Chi CW, Lui WY. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA. Appl Radiat Isot. 2009;67(7–8 Suppl):S105–S108. doi:10.1016/j.apradiso.2009.03.025
   PubMed Web of Science ®Google Scholar
• Hung YH, Lin YC, Lin YT, et al. Suitability of boric acid as a boron drug for boron neutron capture therapy for hepatoma. Appl Radiat Isot. 2020;164:109254. doi:10.1016/j.apradiso.2020.109254
   PubMed Web of Science ®Google Scholar
• Lin S-Y, Lin C-J, Liao J-W, et al. Therapeutic efficacy for hepatocellular carcinoma by boric acid-mediated boron neutron capture therapy in a rat model. Anticancer Res. 2013;33(11):4799–4809.
   PubMed Web of Science ®Google Scholar
• Yang CH, Lin YT, Hung YH, et al. Autoradiographic and histopathological studies of boric acid-mediated BNCT in hepatic VX2 tumor-bearing rabbits: specific boron retention and damage in tumor and tumor vessels. Appl Radiat Isot. 2015;106:176–180. doi:10.1016/j.apradiso.2015.08.034
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
   PubMed Web of Science ®Google Scholar
• Benson R, Madan R, Kilambi R, Chander S. Radiation induced liver disease: a clinical update. J Egypt Natl Canc Inst. 2016;28(1):7–11. doi:10.1016/j.jnci.2015.08.001
   PubMed Web of Science ®Google Scholar
• Kim J, Jung Y. Radiation-induced liver disease: current understanding and future perspectives. Exp Mol Med. 2017;49(7):e359. doi:10.1038/emm.2017.85
   PubMed Web of Science ®Google Scholar
• Guo J, Li L, Guo B, et al. Mechanisms of resistance to chemotherapy and radiotherapy in hepatocellular carcinoma. Transl Cancer Res. 2018;7(3):765–781. doi:10.21037/tcr.2018.05.20
   Web of Science ®Google Scholar
• Fan Q, Yu Y, Zhou Y, Zhang S, Wu C. An emerging role of radiationinduced exosomes in hepatocellular carcinoma progression and radioresistance (Review). Int J Oncol. 2022;60(4). doi:10.3892/ijo.2022.5336
   Web of Science ®Google Scholar
• Llovet JM, Castet F, Heikenwalder M, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19(3):151–172. doi:10.1038/s41571-021-00573-2
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu X, Liang J, et al. Immunotherapy for hepatocellular carcinoma: current status and future prospects. Front Immunol. 2021;12:765101. doi:10.3389/fimmu.2021.765101
   PubMed Web of Science ®Google Scholar
• Kanai T, Endo M, Minohara S, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44(1):201–210. doi:10.1016/S0360-3016(98)00544-6
   PubMed Web of Science ®Google Scholar
• Okayasu R. Repair of DNA damage induced by accelerated heavy ions–a mini review. Int J Cancer. 2012;130(5):991–1000. doi:10.1002/ijc.26445
   PubMed Web of Science ®Google Scholar
• Skarsgard LD. Radiobiology with heavy charged particles: a historical review. Phys Med. 1998;14(Suppl 1):1–19.
   PubMed Web of Science ®Google Scholar
• Chevalier F, Hamdi DH, Lepleux C, et al. High LET radiation overcomes in vitro resistance to X-rays of chondrosarcoma cell lines. Technol Cancer Res Treat. 2019;18:1533033819871309. doi:10.1177/1533033819871309
   Web of Science ®Google Scholar
• Hirota Y, Masunaga S, Kondo N, et al. High linear-energy-transfer radiation can overcome radioresistance of glioma stem-like cells to low linear-energy-transfer radiation. J Radiat Res. 2014;55(1):75–83. doi:10.1093/jrr/rrt095
   PubMed Web of Science ®Google Scholar
• Nakano T, Suzuki Y, Ohno T, et al. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res. 2006;12(7 Pt 1):2185–2190. doi:10.1158/1078-0432.CCR-05-1907
   PubMed Web of Science ®Google Scholar
• Kim EH, Kim MS, Lee KH, et al. Effect of low- and high-linear energy transfer radiation on in vitro and orthotopic in vivo models of osteosarcoma by activation of caspase-3 and −9. Int J Oncol. 2017;51(4):1124–1134. doi:10.3892/ijo.2017.4102
   PubMed Web of Science ®Google Scholar
• Rodriguez C, Carpano M, Curotto P, et al. In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line. Radiat Environ Biophys. 2018;57(2):143–152. doi:10.1007/s00411-017-0729-y
   PubMed Web of Science ®Google Scholar
• Pilie PG, Tang C, Mills GB, Yap TA. State-of-The-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol. 2019;16(2):81–104. doi:10.1038/s41571-018-0114-z
   PubMed Web of Science ®Google Scholar
• Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40(2):179–204. doi:10.1016/j.molcel.2010.09.019
   PubMed Web of Science ®Google Scholar
• Goldstein M, Kastan MB. The DNA damage response: implications for tumor responses to radiation and chemotherapy. Annu Rev Med. 2015;66:129–143. doi:10.1146/annurev-med-081313-121208
   PubMed Web of Science ®Google Scholar
• Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481(7381):287–294. doi:10.1038/nature10760
   PubMed Web of Science ®Google Scholar
• Shimura T, Noma N, Sano Y, et al. AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells. Radiother Oncol. 2014;112(2):302–307. doi:10.1016/j.radonc.2014.07.015
   PubMed Web of Science ®Google Scholar
• Chen KH, Lai ZY, Li DY, Lin YC, Chou FI, Chuang YJ. Analysis of DNA damage responses after boric acid-mediated boron neutron capture therapy in hepatocellular carcinoma. Anticancer Res. 2019;39(12):6661–6671. doi:10.21873/anticanres.13881
   PubMed Web of Science ®Google Scholar
• Nedunchezhian K, Aswath N, Thiruppathy M, Thirugnanamurthy S. Boron neutron capture therapy - A literature review. J Clin Diagn Res. 2016;10(12):ZE01–ZE04. doi:10.7860/JCDR/2016/19890.9024
   PubMedGoogle Scholar
• Tai‐Ze Yuan SQX, Chao‐Nan Q. Boron neutron capture therapy of cancer Critical issues and future prospects. Thoracic Cancer. 2019. doi:10.1111/1759-7714.13232
   PubMed Web of Science ®Google Scholar
• Mariotti LG, Pirovano G, Savage KI, et al. Use of the gamma-H2AX assay to investigate DNA repair dynamics following multiple radiation exposures. PLoS One. 2013;8(11):e79541. doi:10.1371/journal.pone.0079541
   PubMed Web of Science ®Google Scholar
• Shibata A, Conrad S, Birraux J, et al. Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J. 2011;30(6):1079–1092. doi:10.1038/emboj.2011.27
   PubMed Web of Science ®Google Scholar
• Grudzenski S, Raths A, Conrad S, Rube CE, Lobrich M. Inducible response required for repair of low-dose radiation damage in human fibroblasts. Proc Natl Acad Sci U S A. 2010;107(32):14205–14210. doi:10.1073/pnas.1002213107
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang X, Teng L, Legerski RJ. DNA damage checkpoint recovery and cancer development. Exp Cell Res. 2015;334(2):350–358. doi:10.1016/j.yexcr.2015.03.011
   PubMed Web of Science ®Google Scholar
• Taylor WR, Stark GR. Regulation of the G2M transition by p53. Oncogene. 2001;20(15):1803–1815. doi:10.1038/sj.onc.1204252
   PubMed Web of Science ®Google Scholar
• Li D, Sedano S, Allen R, Gong J, Cho M, Sharma S. Current treatment landscape for advanced hepatocellular carcinoma: patient outcomes and the impact on quality of life. Cancers. 2019;11(6):841. doi:10.3390/cancers11060841
   PubMed Web of Science ®Google Scholar
• AGENCY IAE. Relative biological effectiveness in ion beam therapy. Tech Rep. 2008;461:1–65.
   Google Scholar
• Sridharan DM, Asaithamby A, Bailey SM, et al. Understanding cancer development processes after HZE-particle exposure: roles of ROS, DNA damage repair and inflammation. Radiat Res. 2015;183(1):1–26. doi:10.1667/RR13804.1
   PubMed Web of Science ®Google Scholar
• Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell. 2017;66(6):801–817. doi:10.1016/j.molcel.2017.05.015
   PubMed Web of Science ®Google Scholar
• Yajima H, Fujisawa H, Nakajima NI, et al. The complexity of DNA double strand breaks is a critical factor enhancing end-resection. DNA Repair. 2013;12(11):936–946. doi:10.1016/j.dnarep.2013.08.009
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang X, Wang P, et al. Characteristics of DNA-binding proteins determine the biological sensitivity to high-linear energy transfer radiation. Nucleic Acids Res. 2010;38(10):3245–3251. doi:10.1093/nar/gkq069
   PubMed Web of Science ®Google Scholar
• Hada M, Sutherland BM. Spectrum of complex DNA damages depends on the incident radiation. Radiat Res. 2006;165(2):223–230. doi:10.1667/rr3498.1
   PubMed Web of Science ®Google Scholar
• Okayasu R, Okada M, Okabe A, Noguchi M, Takakura K, Takahashi S. Repair of DNA damage induced by accelerated heavy ions in mammalian cells proficient and deficient in the non-homologous end-joining pathway. Radiat Res. 2006;165(1):59–67. doi:10.1667/rr3489.1
   PubMed Web of Science ®Google Scholar
• Sridharan DM, Whalen MK, Almendrala D, et al. Increased Artemis levels confer radioresistance to both high and low LET radiation exposures. Radiat Oncol. 2012;7:96. doi:10.1186/1748-717x-7-96
   PubMed Web of Science ®Google Scholar
• Zhao L, Bao C, Shang Y, et al. The determinant of DNA repair pathway choices in ionising radiation-induced DNA double-strand breaks. Biomed Res Int. 2020;2020:4834965. doi:10.1155/2020/4834965
   PubMed Web of Science ®Google Scholar
• Her J, Bunting SF. How cells ensure correct repair of DNA double-strand breaks. J Biol Chem. 2018;293(27):10502–10511. doi:10.1074/jbc.TM118.000371
   PubMed Web of Science ®Google Scholar
• Nikitaki Z, Velalopoulou A, Zanni V, et al. Key biological mechanisms involved in high-LET radiation therapies with a focus on DNA damage and repair. Expert Rev Mol Med. 2022;24:e15. doi:10.1017/erm.2022.6
   PubMed Web of Science ®Google Scholar
• Kinashi Y, Takahashi S, Kashino G, et al. DNA double-strand break induction in Ku80-deficient CHO cells following boron neutron capture reaction. Radiat Oncol. 2011;6:106. doi:10.1186/1748-717x-6-106
   PubMed Web of Science ®Google Scholar
• Kondo N, Sakurai Y, Hirota Y, et al. DNA damage induced by boron neutron capture therapy is partially repaired by DNA ligase IV. Radiat Environ Biophys. 2016;55(1):89–94. doi:10.1007/s00411-015-0625-2
   PubMed Web of Science ®Google Scholar
• Liu C, Nie J, Wang R, Mao W. The cell cycle G2/M block is an indicator of cellular radiosensitivity. Dose Response. 2019;17(4):1559325819891008. doi:10.1177/1559325819891008
   Web of Science ®Google Scholar
• Granada AE, Jimenez A, Stewart-Ornstein J, et al. The effects of proliferation status and cell cycle phase on the responses of single cells to chemotherapy. Mol Biol Cell. 2020;31(8):845–857. doi:10.1091/mbc.E19-09-0515
   PubMed Web of Science ®Google Scholar
• Cheng L, Brzozowska B, Sollazzo A, et al. Simultaneous induction of dispersed and clustered DNA lesions compromises DNA damage response in human peripheral blood lymphocytes. PLoS One. 2018;13(10):e0204068. doi:10.1371/journal.pone.0204068
   PubMed Web of Science ®Google Scholar
• Nickoloff JA, Sharma N, Taylor L. Clustered DNA double-strand breaks: biological effects and relevance to cancer radiotherapy. Genes. 2020;11(1). doi:10.3390/genes11010099
   PubMed Web of Science ®Google Scholar
• Pang D, Winters TA, Jung M. Radiation-generated short DNA fragments may perturb non-homologous end-joining and induce genomic instability. J Radiat Res. 2011;52(3):309–319. doi:10.1269/jrr.10147
   PubMed Web of Science ®Google Scholar
• Lynn Harrison ZH, Wallace SS, Wallace SS. In vitro repair of synthetic ionizing radiation-induced multiply damaged DNA sites. J Mol Biol. 1999;290:667–684. doi:10.1006/jmbi.1999.2892
   PubMed Web of Science ®Google Scholar
• Cannan WJ, Pederson DS. Mechanisms and consequences of double-strand DNA break formation in chromatin. J Cell Physiol. 2016;231(1):3–14. doi:10.1002/jcp.25048
   PubMed Web of Science ®Google Scholar
• Elbanna M, Chowdhury NN, Rhome R, Fishel ML. Clinical and preclinical outcomes of combining targeted therapy with radiotherapy. Front Oncol. 2021;11:749496. doi:10.3389/fonc.2021.749496
   PubMed Web of Science ®Google Scholar
• Yang SH, Kuo TC, Wu H, et al. Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer. World J Gastroenterol. 2016;22(32):7275–7288. doi:10.3748/wjg.v22.i32.7275
   PubMed Web of Science ®Google Scholar
• King HO, Brend T, Payne HL, et al. RAD51 is a selective DNA repair target to radiosensitize glioma stem cells. Stem Cell Rep. 2017;8(1):125–139. doi:10.1016/j.stemcr.2016.12.005
   PubMed Web of Science ®Google Scholar
• Cuneo KC, Morgan MA, Sahai V, et al. Dose escalation trial of the Wee1 Inhibitor Adavosertib (AZD1775) in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer. J Clin Oncol. 2019;37(29):2643–2650. doi:10.1200/jco.19.00730
   PubMed Web of Science ®Google Scholar
• Kong A, Good J, Kirkham A, et al. Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol. BMJ Open. 2020;10(3):e033009. doi:10.1136/bmjopen-2019-033009
   PubMed Web of Science ®Google Scholar
• Zhao Y, Foster NR, Meyers JP, et al. A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321. J Thorac Oncol. 2015;10(1):172–180. doi:10.1097/jto.0000000000000383
   PubMed Web of Science ®Google Scholar
• Sakaguchi H, Tsuchiya H, Kitagawa Y, et al. NEAT1 confers radioresistance to hepatocellular carcinoma cells by inducing autophagy through GABARAP. Int J Mol Sci. 2022;23(2):711. doi:10.3390/ijms23020711
   PubMed Web of Science ®Google Scholar
• Peng WX, Wan YY, Gong AH, et al. Egr-1 regulates irradiation-induced autophagy through Atg4B to promote radioresistance in hepatocellular carcinoma cells. Oncogenesis. 2017;6(1):e292. doi:10.1038/oncsis.2016.91
   PubMed Web of Science ®Google Scholar